Your browser doesn't support javascript.
loading
Easing the Journey-an Updated Review of Palliative Care for the Patient with High-Grade Glioma.
Crooms, Rita C; Johnson, Margaret O; Leeper, Heather; Mehta, Ambereen; McWhirter, Michelle; Sharma, Akanksha.
Afiliação
  • Crooms RC; Department of Neurology, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, 1052, NY, 10029, New York, USA.
  • Johnson MO; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Leeper H; Department of Neurosurgery, Duke University Medical Center, Trent Drive 047 Baker House, Durham, NC, 27710, USA.
  • Mehta A; The Preston Robert Tirsch Brain Tumor Center, Duke University Medical Center, Trent Drive 047 Baker House, NC, 27710, Durham, USA.
  • McWhirter M; Neuro-Oncology Branch, National Institutes of Health, National Cancer Institute, 9030 Old Georgetown Rd, Bloch Bldg 82, Bethesda, MD, 20892, USA.
  • Sharma A; Palliative Care Program, Division of Medicine, Johns Hopkins School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, 21224, MD, USA.
Curr Oncol Rep ; 24(4): 501-515, 2022 04.
Article em En | MEDLINE | ID: mdl-35192120
ABSTRACT
PURPOSE OF REVIEW High-grade gliomas (HGG) are rare brain tumors that cause disproportionate suffering and mortality. Palliative care, whose aim is to relieve the symptoms and stressors of serious illness, may benefit patients with HGG and their families. In this review, we summarize the extant literature and provide recommendations for addressing the symptom management and communication needs of brain tumor patients and their caregivers at key points in the illness trajectory initial diagnosis; during upfront treatment; disease recurrence; end-of-life period; and after death during bereavement. RECENT

FINDINGS:

Patients with HGG experience highly intrusive symptoms, cognitive and functional decline, and emotional and existential distress throughout the disease course. The caregiver burden is also substantial during the patient's illness and after death. There is limited evidence to guide the palliative management of these issues. Palliative care is likely to benefit patients with HGG, yet further research is needed to optimize the delivery of palliative care in neuro-oncology.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Assistência Terminal / Neoplasias Encefálicas / Glioma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Curr Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Assistência Terminal / Neoplasias Encefálicas / Glioma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Curr Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos